GE HealthCare has been actively launching new products and announcing significant developments in recent months. Here are the latest news items from the company:
## Recent Announcements
On May 12, 2025, GE HealthCare unveiled an ultra-premium, high-performance gradient 1.5T MRI system, demonstrating their leadership in high-performance gradient technology with the introduction of HyperG gradients[4].
In March 2025, the company advanced its cloud strategy by unveiling the Genesis Portfolio, designed to improve the speed of digital innovation adoption[1].
GE HealthCare has also launched several AI-driven solutions recently, including:
– Invenia ABUS Premium, a patient-friendly solution to accelerate scanning and drive early cancer detection in dense breasts[1]
– New autonomous X-ray and ultrasound solutions developed in collaboration with NVIDIA[1]
– AltiX AI.i, expanding their invasive cardiology solutions portfolio for enhanced experiences in catheterization lab and electrophysiology procedures[1]
## Technology Innovations
The company has introduced Freelium, a next-generation sealed magnet platform, at ECR 2025 to support equitable and sustainable access to MR technology[1].
In the ultrasound space, GE HealthCare continues to showcase leadership with advancements in their portfolio:
– Their LOGIQ ultrasound systems celebrated 30 years of innovations designed for general imaging needs across multiple care areas including radiology, vascular, breast, and OB/GYN[5]
– The flagship LOGIQ E10 Series provides capabilities for full body imaging with AI-driven workflow efficiency[5]
– LOGIQ Fortis represents next-generation technology with compact design and cSound Architecture for high-quality imaging[5]
## Business Developments
GE HealthCare has announced a $138 million investment in their Cork, Ireland manufacturing facility to address increasing contrast media demand[1].
The company has also named a new president and CEO for their China operations[1].
Additionally, patients in the US have undergone the first doses of GE HealthCare’s new PET radiotracer, Flyrcado (flurpiridaz F 18) injection[1].